194 filings
6-K
EVAX
Evaxion Biotech A/S
26 Jun 24
Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method
8:30am
6-K
EVAX
Evaxion Biotech A/S
24 Jun 24
Current report (foreign)
4:50pm
6-K
EVAX
Evaxion Biotech A/S
18 Jun 24
Current report (foreign)
4:30pm
6-K
EVAX
Evaxion Biotech A/S
17 Jun 24
Current report (foreign)
9:13am
6-K
EVAX
Evaxion Biotech A/S
7 Jun 24
Current report (foreign)
5:00pm
6-K
zg82u9n0 6zi
3 Jun 24
Current report (foreign)
9:25am
6-K
05gkjj1 2bl0
3 Jun 24
Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024
8:30am
6-K
b8kavhksxx
28 May 24
Evaxion Announces Business Update and First Quarter 2024 Financial Results
9:30am
6-K
0nh 8moby5qpfj
24 May 24
Current report (foreign)
4:30pm
6-K
xsl5jak
23 May 24
Current report (foreign)
5:05pm
6-K
3q0ux8vkgxwqh p1k
10 May 24
Evaxion Receives Nasdaq Notification
5:29pm
F-1
gjilk33ic lpmqftbj
6 May 24
Registration statement (foreign)
5:01pm
6-K
9qdl60z285wqbnlko1k
25 Apr 24
Current report (foreign)
5:30pm
6-K
8gwr1nb9g2kgi8xtk
17 Apr 24
Current report (foreign)
9:30am
6-K
cuvsv7mt
2 Apr 24
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
8:00am
6-K
4g43zbc 955ms6lktg
29 Mar 24
Notice of Annual General Meeting
8:30am
6-K
coy x889zn
27 Mar 24
Evaxion Announces Business Update and Full Year 2023 Financial Results
8:30am
6-K
c0jk59n 1jz
19 Mar 24
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
8:17am
6-K
g2kks 0f12s1tae
13 Mar 24
Current report (foreign)
4:30pm